These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 24944075)

  • 1. The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
    Handley AP; Williams M
    J Am Assoc Nurse Pract; 2015 Jan; 27(1):54-61. PubMed ID: 24944075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.
    Stubbs C; Mattingly L; Crawford SA; Wickersham EA; Brockhaus JL; McCarthy LH
    J Okla State Med Assoc; 2017 May; 110(5):272-274. PubMed ID: 28649145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials.
    Azizi M; Khani S; Kamali M; Elyasi F
    Iran J Med Sci; 2022 May; 47(3):173-193. PubMed ID: 35634530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
    Kishi T; Ikuta T; Sakuma K; Okuya M; Hatano M; Matsuda Y; Iwata N
    Mol Psychiatry; 2023 Jan; 28(1):402-409. PubMed ID: 36253442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of citalopram and venlafaxine's role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial.
    Davari-Tanha F; Soleymani-Farsani M; Asadi M; Shariat M; Shirazi M; Hadizadeh H
    Arch Gynecol Obstet; 2016 May; 293(5):1007-13. PubMed ID: 26437957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of antidepressants for management of hot flashes.
    Carroll DG; Kelley KW
    Pharmacotherapy; 2009 Nov; 29(11):1357-74. PubMed ID: 19857151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
    Strawn JR; Mills JA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonestrogen treatment modalities for vasomotor symptoms associated with menopause.
    Fugate SE; Church CO
    Ann Pharmacother; 2004 Sep; 38(9):1482-99. PubMed ID: 15292498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonhormonal Pharmacotherapies for the Treatment of Postmenopausal Vasomotor Symptoms.
    Witten T; Staszkiewicz J; Gold L; Granier MA; Klapper RJ; Lavespere G; Dorius B; Allampalli V; Ahmadzadeh S; Shekoohi S; Kaye AD; Varrassi G
    Cureus; 2024 Jan; 16(1):e52467. PubMed ID: 38371081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.
    Speroff L; Gass M; Constantine G; Olivier S;
    Obstet Gynecol; 2008 Jan; 111(1):77-87. PubMed ID: 18165395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing vasomotor symptoms in women after cancer.
    Pinkerton JV; Santen RJ
    Climacteric; 2019 Dec; 22(6):544-552. PubMed ID: 31081391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis.
    Renoux C; Lix LM; Patenaude V; Bresee LC; Paterson JM; Lafrance JP; Tamim H; Mahmud SM; Alsabbagh MW; Hemmelgarn B; Dormuth CR; Ernst P;
    Clin J Am Soc Nephrol; 2015 Oct; 10(10):1716-22. PubMed ID: 26231193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Inquiries: Does exercise relieve vasomotor menopausal symptoms?
    Lyon C; Mullen R; Deffenbacher B; Reed A; Nashelsky J
    J Fam Pract; 2018 Mar; 67(3):175-176. PubMed ID: 29509823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating vasomotor symptoms of menopause: the nurse practitioner's perspective.
    Alexander IM; Moore A
    J Am Acad Nurse Pract; 2007 Mar; 19(3):152-63. PubMed ID: 17341283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of nonhormonal drugs on menopausal hot flashes.
    Li L; Xu L; Wu J; Dong L; Zhao S; Zheng Q
    Eur J Clin Pharmacol; 2016 Sep; 72(9):1051-8. PubMed ID: 27450233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenergic and serotonergic modulation to treat vasomotor symptoms.
    Albertazzi P
    J Br Menopause Soc; 2006 Mar; 12(1):7-11. PubMed ID: 16513016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and Comparison of Citalopram and Venlafaxine for Management of Hot Flashes in Women with Breast Cancer.
    Taleghani SY; Etesam F; Esfandbod M
    Drug Res (Stuttg); 2023 Oct; 73(8):465-472. PubMed ID: 37647930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Inquiry: Which nonhormonal treatments are effective for hot flashes?
    Kelsberg G; Maragh L; Safranek S
    J Fam Pract; 2016 May; 65(5):E1-3. PubMed ID: 27275942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurokinin 3 Receptor Antagonists Compared With Serotonin Norepinephrine Reuptake Inhibitors for Non-Hormonal Treatment of Menopausal Hot Flushes: A Systematic Qualitative Review.
    Menown SJ; Tello JA
    Adv Ther; 2021 Oct; 38(10):5025-5045. PubMed ID: 34514552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.